159 related articles for article (PubMed ID: 37978114)
1. Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in Males: An NCDB Analysis of the Surgical Approach to DCIS in Males.
Carter MM; Whitrock JN; Pratt CG; Shaughnessy EA; Meier TM; Barrord MF; Hanseman DJ; Reyna CR; Heelan AA; Lewis JD
Ann Surg Oncol; 2024 Mar; 31(3):1599-1607. PubMed ID: 37978114
[TBL] [Abstract][Full Text] [Related]
2. Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study.
Nguyen TT; Hoskin TL; Day CN; Habermann EB; Goetz MP; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2989-2998. PubMed ID: 28766214
[TBL] [Abstract][Full Text] [Related]
3. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
[TBL] [Abstract][Full Text] [Related]
4. Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors.
Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC; Oseni TO
Ann Surg Oncol; 2019 Nov; 26(12):3863-3873. PubMed ID: 31325048
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.
Tesch ME; Rosenberg SM; Collins LC; Wong JS; Dominici L; Ruddy KJ; Tamimi R; Schapira L; Borges VF; Warner E; Come SE; Partridge AH
Ann Surg Oncol; 2022 Dec; 29(13):8048-8057. PubMed ID: 35960452
[TBL] [Abstract][Full Text] [Related]
6. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
[TBL] [Abstract][Full Text] [Related]
7. Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database.
Frebault J; Bergom C; Cortina CS; Shukla ME; Zhang Y; Huang CC; Kong AL
Clin Breast Cancer; 2022 Aug; 22(6):547-552. PubMed ID: 35595612
[TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
[No Abstract] [Full Text] [Related]
9. Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes.
Halasz SR; O'Keefe T; Wallace AM; Blair SL
Breast Cancer Res Treat; 2021 Apr; 186(2):551-559. PubMed ID: 33180236
[TBL] [Abstract][Full Text] [Related]
10. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
[TBL] [Abstract][Full Text] [Related]
11. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer.
Kruper L; Xu X; Henderson K; Bernstein L
Ann Surg Oncol; 2011 Oct; 18(11):3210-9. PubMed ID: 21863363
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
13. Trends in the treatment of ductal carcinoma in situ of the breast.
Baxter NN; Virnig BA; Durham SB; Tuttle TM
J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
[TBL] [Abstract][Full Text] [Related]
14. Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 Years of follow-up.
ElSherif A; Freyvogel Ramirez M; Moore EC; Dietz JR; Tu C; Valente SA
Am J Surg; 2023 Nov; 226(5):646-651. PubMed ID: 37481406
[TBL] [Abstract][Full Text] [Related]
15. Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.
Sagara Y; Freedman RA; Wong SM; Aydogan F; Nguyen A; Barry WT; Golshan M
Breast Cancer Res Treat; 2017 Nov; 166(2):583-592. PubMed ID: 28776282
[TBL] [Abstract][Full Text] [Related]
16. Rural-urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis.
Riley D; Chrischilles EA; Lizarraga IM; Charlton M; Smith BJ; Lynch CF
Cancer Med; 2022 Jun; 11(11):2284-2295. PubMed ID: 35146946
[TBL] [Abstract][Full Text] [Related]
17. Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.
Greenberg CC; Habel LA; Hughes ME; Nekhlyudov L; Achacoso N; Acton L; Schrag D; Jiang W; Edge S; Weeks JC; Punglia RS
Ann Surg Oncol; 2014 Nov; 21(12):3766-73. PubMed ID: 24859938
[TBL] [Abstract][Full Text] [Related]
18. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
[TBL] [Abstract][Full Text] [Related]
19. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ.
Song HM; Styblo TM; Carlson GW; Losken A
Breast J; 2010; 16(2):141-6. PubMed ID: 20102367
[TBL] [Abstract][Full Text] [Related]
20. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]